Literature DB >> 34724611

Substrate Sequence Controls Regioselectivity of Lanthionine Formation by ProcM.

Tung Le1, Kevin Jeanne Dit Fouque2, Miguel Santos-Fernandez2, Claudio D Navo3,4, Gonzalo Jiménez-Osés3,4, Raymond Sarksian1, Francisco Alberto Fernandez-Lima2, Wilfred A van der Donk1.   

Abstract

Lanthipeptides belong to the family of ribosomally synthesized and post-translationally modified peptides (RiPPs). The (methyl)lanthionine cross-links characteristic to lanthipeptides are essential for their stability and bioactivities. In most bacteria, lanthipeptides are maturated from single precursor peptides encoded in the corresponding biosynthetic gene clusters. However, cyanobacteria engage in combinatorial biosynthesis and encode as many as 80 substrate peptides with highly diverse sequences that are modified by a single lanthionine synthetase into lanthipeptides of different lengths and ring patterns. It is puzzling how a single enzyme could exert control over the cyclization processes of such a wide range of substrates. Here, we used a library of ProcA3.3 precursor peptide variants and show that it is not the enzyme ProcM but rather its substrate sequences that determine the regioselectivity of lanthionine formation. We also demonstrate the utility of trapped ion mobility spectrometry-tandem mass spectrometry (TIMS-MS/MS) as a fast and convenient method to efficiently separate lanthipeptide constitutional isomers, particularly in cases where the isomers cannot be resolved by conventional liquid chromatography. Our data allowed identification of factors that are important for the cyclization outcome, but also showed that there are no easily identifiable predictive rules for all sequences. Our findings provide a platform for future deep learning approaches to allow such prediction of ring patterns of products of combinatorial biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34724611      PMCID: PMC8942616          DOI: 10.1021/jacs.1c09370

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  63 in total

Review 1.  Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides.

Authors:  Avena C Ross; John C Vederas
Journal:  J Antibiot (Tokyo)       Date:  2010-11-17       Impact factor: 2.649

2.  Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.

Authors:  Paul D Cotter; Lucy H Deegan; Elaine M Lawton; Lorraine A Draper; Paula M O'Connor; Colin Hill; R Paul Ross
Journal:  Mol Microbiol       Date:  2006-11       Impact factor: 3.501

3.  Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.

Authors:  Qian Li; Manuel Montalban-Lopez; Oscar P Kuipers
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

4.  O-Methyltransferase-Mediated Incorporation of a β-Amino Acid in Lanthipeptides.

Authors:  Jeella Z Acedo; Ian R Bothwell; Linna An; Abby Trouth; Clara Frazier; Wilfred A van der Donk
Journal:  J Am Chem Soc       Date:  2019-10-15       Impact factor: 15.419

5.  Analysis of isomeric opioids in urine using LC-TIMS-TOF MS.

Authors:  Kendra J Adams; Cesar E Ramirez; Natalie F Smith; Ana Celia Muñoz-Muñoz; Lawrence Andrade; Francisco Fernandez-Lima
Journal:  Talanta       Date:  2018-02-19       Impact factor: 6.057

Review 6.  New developments in RiPP discovery, enzymology and engineering.

Authors:  Manuel Montalbán-López; Thomas A Scott; Sangeetha Ramesh; Imran R Rahman; Auke J van Heel; Jakob H Viel; Vahe Bandarian; Elke Dittmann; Olga Genilloud; Yuki Goto; María José Grande Burgos; Colin Hill; Seokhee Kim; Jesko Koehnke; John A Latham; A James Link; Beatriz Martínez; Satish K Nair; Yvain Nicolet; Sylvie Rebuffat; Hans-Georg Sahl; Dipti Sareen; Eric W Schmidt; Lutz Schmitt; Konstantin Severinov; Roderich D Süssmuth; Andrew W Truman; Huan Wang; Jing-Ke Weng; Gilles P van Wezel; Qi Zhang; Jin Zhong; Jörn Piel; Douglas A Mitchell; Oscar P Kuipers; Wilfred A van der Donk
Journal:  Nat Prod Rep       Date:  2020-09-16       Impact factor: 15.111

7.  Incorporation of tryptophan analogues into the lantibiotic nisin.

Authors:  Liang Zhou; Jinfeng Shao; Qian Li; Auke J van Heel; Marcel P de Vries; Jaap Broos; Oscar P Kuipers
Journal:  Amino Acids       Date:  2016-02-12       Impact factor: 3.520

8.  Chimeric Leader Peptides for the Generation of Non-Natural Hybrid RiPP Products.

Authors:  Brandon J Burkhart; Nidhi Kakkar; Graham A Hudson; Wilfred A van der Donk; Douglas A Mitchell
Journal:  ACS Cent Sci       Date:  2017-06-06       Impact factor: 14.553

9.  Insights into AMS/PCAT transporters from biochemical and structural characterization of a double Glycine motif protease.

Authors:  Silvia C Bobeica; Shi-Hui Dong; Liujie Huo; Nuria Mazo; Martin I McLaughlin; Gonzalo Jiménez-Osés; Satish K Nair; Wilfred A van der Donk
Journal:  Elife       Date:  2019-01-14       Impact factor: 8.140

Review 10.  Bioengineering Lantibiotics for Therapeutic Success.

Authors:  Des Field; Paul D Cotter; Colin Hill; R P Ross
Journal:  Front Microbiol       Date:  2015-11-27       Impact factor: 5.640

View more
  3 in total

1.  Trapped Ion Mobility Spectrometry, Ultraviolet Photodissociation, and Time-of-Flight Mass Spectrometry for Gas-Phase Peptide Isobars/Isomers/Conformers Discrimination.

Authors:  Samuel A Miller; Kevin Jeanne Dit Fouque; Mark E Ridgeway; Melvin A Park; Francisco Fernandez-Lima
Journal:  J Am Soc Mass Spectrom       Date:  2022-06-05       Impact factor: 3.262

2.  Accurate Models of Substrate Preferences of Post-Translational Modification Enzymes from a Combination of mRNA Display and Deep Learning.

Authors:  Alexander A Vinogradov; Jun Shi Chang; Hiroyasu Onaka; Yuki Goto; Hiroaki Suga
Journal:  ACS Cent Sci       Date:  2022-05-26       Impact factor: 18.728

3.  Divergent Evolution of Lanthipeptide Stereochemistry.

Authors:  Raymond Sarksian; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2022-08-24       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.